People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| K2 Biolabs, Inc. | — | Biotechnology | Series A | $6.1M | $5.4M | 2021 |
Andrew DeSomma at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew DeSomma on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clifford Stocks | 1 | 5 |
| Daniel J. Clark | 1 | 2 |
| Clifford J. Stocks | 1 | 2 |
| Kevin Slawin | 1 | 2 |
| Gerard Fleury | 1 | 2 |
| Andrew Strong | 1 | 1 |
| Andrew J. Strong | 1 | 1 |
| Kieron Jones | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.